sporotrichosi
mycosi
affect
human
anim
global
caus
differ
member
sporothrix
schenckii
speci
complex
includ
brasiliensi
schenckii
sensu
stricto
str
globosa
luriei
zoonot
transmiss
gener
occur
infecti
diseas
ini
oswaldo
cruz
foundat
fiocruz
period
april
august
opportunist
sampl
compris
cat
sporotrichosi
show
skin
lesion
previou
antifung
corticosteroid
therapi
diagnosi
sporotrichosi
confirm
isol
identif
sporothrix
spp
cat
includ
studi
divid
three
group
accord
distribut
skin
lesion
briefli
group
includ
cat
lesion
one
locat
group
includ
cat
lesion
two
noncontigu
locat
group
includ
cat
lesion
three
noncontigu
locat
gener
condit
anim
classifi
good
absenc
extracutan
sign
fair
presenc
mild
dyspnea
conjunct
weight
loss
dehydr
hypocolor
mucosa
prostrat
poor
worsen
sign
describ
fair
group
previous
describ
blood
sampl
obtain
jugular
venipunctur
divid
three
tube
follow
ml
blood
transfer
tube
contain
edta
ethylenediaminetetraacet
acid
qpcr
rtqpcr
detect
felv
proviru
cytokin
transcript
studi
respect
ml
transfer
tube
contain
heparin
bd
vacutain
franklin
lake
nj
usa
peripher
blood
mononuclear
cell
pbmc
isol
flow
cytometri
ml
transfer
tube
without
anticoagul
serum
elisa
western
blot
detect
fiv
antibodi
elisa
detect
felv
antigen
heparin
blood
sampl
pbmc
sampl
serum
sampl
store
liquid
nitrogen
respect
analysi
follow
analys
perform
clinic
laboratori
vetsuiss
faculti
univers
switzerland
procedur
perform
anim
well
use
storag
biolog
sampl
approv
anim
use
ethic
committe
fiocruz
licens
number
owner
cat
includ
studi
provid
sign
inform
consent
prior
sampl
collect
cat
follow
outpati
basi
lapclindermzoo
followup
data
regard
treatment
protocol
clinic
outcom
cure
failur
time
cure
obtain
medic
record
initi
sampl
diagnosi
cat
receiv
antifung
therapi
oral
itraconazol
itz
mgcatday
oral
itz
mgcatday
combin
potassium
iodid
ki
capsul
mgkgday
criteria
clinic
cure
therapeut
failur
previous
describ
rei
et
al
cat
present
heal
skinmucos
lesion
remiss
clinic
sign
consid
clinic
cure
therapeut
failur
consid
outcom
clinic
improv
observ
two
consecut
appoint
clinic
recurr
occur
time
week
treatment
provid
clinic
cure
serolog
assay
determin
felin
leukemia
viru
antigenemia
presenc
antifelin
immunodefici
viru
antibodi
detect
felv
viremia
presenc
felv
antigen
plasma
determin
use
sandwich
elisa
previous
describ
result
repres
percentag
defin
posit
control
cultur
supernat
felin
lymphoblastoid
cell
line
perman
express
felv
consid
sampl
determin
posit
control
signal
consid
posit
serum
test
elisa
fiv
antibodi
use
recombin
transmembran
glycoprotein
tmelisa
describ
elsewher
sampl
reach
od
valu
posit
control
consid
posit
presenc
antibodi
fiv
confirm
western
blot
refer
standard
method
techniqu
describ
previous
presenc
band
band
interpret
posit
test
result
taqman
realtim
qpcr
assay
detect
felin
leukemia
viru
proviru
dna
purifi
edta
blood
sampl
use
magna
pure
lc
tna
isol
kit
roch
diagnost
rotkreuz
switzerland
felv
provir
dna
test
taqman
realtim
qpcr
refer
standard
method
previous
describ
assess
cytokin
profil
within
one
hour
collect
aliquot
whole
blood
collect
edta
tube
admix
mrna
lysi
buffer
mrna
isol
hs
kit
roch
diagnost
respect
store
subsequ
analysi
mrna
purifi
mrna
isol
kit
magna
pure
lc
instrument
roch
diagnost
accord
manufactur
recommend
extract
perform
phosphat
buffer
salin
pb
use
neg
control
order
monitor
crosscontamin
mrna
elut
elut
buffer
firststrand
cdna
synthes
use
high
capac
cdna
revers
transcript
kit
appli
biosystem
accord
manufactur
instruct
sampl
mrna
cdna
synthet
duplic
pool
taqman
realtim
rtqpcr
assay
use
rel
quantif
follow
cytokin
interleukin
il
tumor
necrosi
previous
describ
level
transcript
vabl
abelson
murin
leukemia
viral
oncogen
abl
zeta
polypeptid
ywhaz
previous
refer
bestperform
housekeep
gene
felin
blood
due
stabl
transcript
employ
normal
briefli
assess
transcript
level
cytokin
refer
gene
sampl
studi
standard
curv
acquir
use
serial
dilut
synthet
standard
afterward
transcript
level
cytokin
normal
geometr
mean
housekeep
gene
describ
elsewher
assess
lymphocyt
subset
flow
cytometri
isol
felin
pbmc
carri
use
commerci
avail
densiti
gradient
ficollhystopaquedens
gml
histopaquesigmaaldrich
buch
switzerland
report
previous
hour
blood
collect
pellet
resuspend
freez
medium
dmso
sigmaaldrich
fetal
calf
serum
fc
hycloneusa
rpmi
roswel
park
memori
institutesigmaaldrich
medium
store
liquid
nitrogen
flow
cytometri
analysi
pbmc
quickli
thaw
resuspend
ml
complet
medium
rpmi
mediumsigmaaldrich
zug
switzerland
contain
fc
mml
glutamin
vv
antibioticantimycot
abam
gibco
life
technolog
zug
switzerland
previous
warm
solut
centrifug
x
g
minut
cell
wash
ml
hbss
hank
balanc
salt
solut
sigmaaldrich
pellet
resuspend
ml
hbss
three
aliquot
pbmc
incub
minut
one
antibodycombin
antibodi
previous
dilut
hbss
mous
antifelin
abdserotec
germani
mous
antifelin
southern
biotech
allschwil
switzerland
mous
antifelin
southern
biotech
mous
anticanin
abd
serotec
crossreact
felin
unlabel
sampl
employ
neg
control
nonspecif
bind
incub
cell
wash
twice
centrifug
hbss
resuspend
hbss
acquisit
flow
cytomet
cytofluorimetr
analysi
perform
use
guava
easycyt
flow
cytomet
millipor
darmstadt
germani
use
guavasoft
softwar
data
analysi
popul
lymphocyt
defin
basi
size
granular
forward
side
scatter
gate
set
analysi
data
collect
cell
express
percentag
posit
cell
insid
gate
statist
data
store
analyz
statist
packag
social
scienc
spss
version
follow
categor
variabl
use
group
cat
analys
coinfect
fiv
felv
posit
neg
gener
condit
good
fair
poor
distribut
lesion
regard
coinfect
felv
progress
felvinfect
cat
includ
statist
analys
compar
cat
without
retroviru
infect
cat
regress
felv
infect
exclud
analys
concern
fiv
cat
consid
fivposit
confirm
posit
western
blot
pearson
chisquar
test
independ
use
determin
signific
associ
categor
variabl
fisher
exact
test
pf
appli
comparison
variabl
two
categori
mannwhitney
utest
p
mwu
kruskallw
p
kw
test
perform
test
statist
differ
cytokin
transcript
percentag
lymphocyt
subset
treatment
length
two
group
among
mani
group
respect
pvalu
equal
consid
signific
thirti
cat
sporotrichosi
includ
studi
six
cat
includ
group
ten
group
fourteen
group
twentyon
cat
male
twentyfour
good
gener
condit
three
fair
gener
condit
three
poor
gener
condit
fourteen
cat
year
old
year
six
five
year
old
year
seven
five
year
old
year
three
adult
cat
age
class
unknown
among
thirti
cat
sporotrichosi
includ
studi
three
posit
fiv
antibodi
six
posit
felv
proviru
tabl
none
cat
doubleposit
felv
fiv
case
test
posit
fiv
antibodi
elisa
test
also
posit
fiv
westernblot
detect
also
antibodi
fiv
moreov
cat
test
posit
felv
antigen
elisa
test
also
posit
felv
realtim
qpcr
assay
detect
felv
proviru
use
elisa
alon
result
one
fals
neg
case
fiv
cat
fivelisa
neg
fiv
western
blot
posit
regard
fivinfect
one
felvexpos
cat
proviru
posit
without
detect
antigenemia
cat
consid
statist
analys
concern
retroviru
infect
sinc
categor
regress
felv
infect
poor
gener
condit
observ
two
three
fiv
posit
cat
associ
fiv
infect
compar
retrovirusneg
cat
p
f
cat
progress
felv
infect
poor
gener
condit
observ
one
five
cat
among
cat
test
neg
retrovirus
n
good
gener
condit
fair
gener
condit
none
present
poor
gener
condit
thu
cat
present
poor
gener
condit
coinfect
either
felv
progress
infect
fiv
none
retrovirusneg
cat
present
poor
gener
condit
p
f
assess
cytokin
profil
mean
quantit
rtpcr
perform
anim
compar
retrovirusneg
cat
sporotrichosi
signific
differ
found
among
cat
group
cytokin
transcript
test
cytokin
tabl
possibl
compar
cytokin
level
among
cat
retroviru
coinfect
accord
gener
condit
due
small
number
n
anim
fair
gener
condit
analyz
cytokin
level
accord
retroviru
statu
significantli
higher
transcript
level
found
fivposit
cat
cat
progress
felv
infect
compar
retrovirusneg
cat
fig
moreov
cat
progress
felv
infect
also
significantli
lower
level
fivinfect
cat
significantli
lower
fig
compar
retrovirusneg
cat
signific
differ
found
transcript
level
analysi
done
cat
studi
sinc
live
cell
recoveri
thaw
low
perform
assay
one
felvposit
cat
signific
differ
lymphocyt
subset
among
cat
group
tabl
consid
retrovir
infect
fivposit
cat
sporotrichosi
significantli
lower
higher
cell
retrovirusneg
cat
sporotrichosi
fig
invers
ratio
present
two
three
fivposit
cat
observ
cat
progress
felv
infect
retrovirusneg
cat
fivposit
cat
significantli
lower
ratio
compar
retrovirusneg
cat
p
mwu
signific
differ
observ
fivposit
retrovirusneg
cat
felin
cell
b
cell
addit
signific
differ
test
lymphocyt
subset
cat
progress
felv
infect
compar
retrovirusneg
cat
base
data
collect
medic
record
cat
follow
treatment
outcom
four
retrovirusneg
cat
one
cat
progress
felv
infect
lost
follow
among
remain
retrovirusneg
cat
n
clinic
cure
observ
sixteen
therapeut
failur
one
cat
among
remain
cat
progress
felv
infect
n
three
treat
itzki
cure
fivposit
cat
n
treat
itz
alon
two
cure
cure
rate
relat
treatment
protocol
retroviru
statu
tabl
show
therapeut
aspect
cat
studi
accord
retroviru
statu
treatment
length
statist
differ
group
regardless
therapeut
protocol
retroviru
statu
among
cat
clinic
cure
overal
median
treatment
length
week
week
retrovirusneg
cat
week
cat
progress
felv
infect
week
fivposit
cat
median
treatment
length
retrovirusneg
cat
higher
therapeut
protocol
use
itz
alon
median
week
compar
itz
ki
median
week
cat
progress
felv
infect
treatment
length
also
higher
cat
treat
itz
alon
median
week
comparison
treat
itzki
median
week
studi
cat
sporotrichosi
investig
felin
retroviru
coinfect
immunolog
aspect
base
cytokin
express
profil
peripher
blood
mononuclear
cell
best
knowledg
first
studi
assess
cytokin
transcript
blood
cat
sporotrichosi
previou
studi
establish
correl
sever
sporotrichosi
felin
retroviru
coinfect
like
explain
use
clinic
therapeut
aspect
case
definit
recent
miranda
et
al
describ
leukocyt
profil
blood
cat
sporotrichosi
fiv
coinfect
cat
number
felv
coinfect
cat
limit
statist
correl
leukocyt
profil
could
establish
present
studi
also
low
incid
felv
fiv
infect
cat
may
reduc
statist
power
detect
signific
differ
potenti
caus
retroviru
infect
low
incid
retroviru
infect
studi
popul
cat
lack
confirm
posit
test
result
studi
use
gold
standard
method
led
increas
likelihood
fals
posit
case
identifi
previou
report
low
posit
predict
valu
screen
result
current
studi
diagnos
fiv
statu
cat
western
blot
techniqu
consid
gold
standard
method
detect
fiv
antibodi
area
without
vaccin
appli
occurr
fals
neg
case
use
elisa
previous
report
calzolari
et
al
four
cat
test
neg
fiv
tm
elisa
posit
western
blot
previous
observ
lack
reactiv
recombin
tm
fiv
infect
domest
cat
may
inde
due
infect
fiv
distinct
tm
antigen
util
elisa
realtim
pcr
employ
detect
quantifi
felv
proviru
addit
felv
antigen
detect
elisa
pcr
sensit
measur
felv
exposur
antigen
detect
felv
proviruspositiveantigenneg
cat
describ
regress
felv
infect
current
studi
one
cat
regress
felvinfect
small
number
n
felv
regress
infect
case
cat
includ
statist
analysi
separ
group
moreov
also
includ
cat
progress
felv
infect
cat
sinc
cat
expect
present
major
immunolog
chang
stage
howev
sinc
cat
latent
infect
subsequ
reactiv
viremia
rule
especi
case
comorbid
immunosuppress
chronic
stress
cat
regress
felv
infect
monitor
reappear
felv
antigen
becom
posit
need
consid
potenti
sourc
felv
infect
probabl
show
immunolog
chang
studi
regard
immun
respons
human
sporotrichosi
scarc
howev
correl
sever
sporotrichosi
coinfect
hiv
establish
clinic
patholog
present
sporotrichosi
hivposit
patient
often
compar
seen
cat
sporotrichosi
whether
coinfect
retroviru
studi
show
signific
associ
poor
gener
condit
cat
sporotrichosi
coinfect
fiv
felin
retrovirus
gener
suggest
retroviru
coinfect
may
influenc
clinic
present
cat
sporotrichosi
normal
geometr
mean
housekeep
gene
yax
significantli
lower
p
mwu
cat
progress
felv
infect
significantli
lower
p
mwu
fivposit
cat
comparison
retrovirusneg
cat
significantli
higher
cat
progress
felv
infect
p
mwu
fivposit
cat
p
mwu
comparison
retrovirusneg
cat
p
mwu
reduc
transcript
level
fiv
coinfect
cat
compar
retrovirusneg
cat
studi
suggest
alter
perhap
compromis
cellular
immun
respons
cat
significantli
increas
cat
sporotrichosi
coinfect
either
fiv
felv
lead
potenti
immunosuppress
condit
sinc
cytokin
wide
involv
immunoregulatori
effect
also
immun
respons
retrovirussporothrix
coinfect
cat
report
suppress
cellular
immun
respons
inhibit
cytokin
product
cell
activ
macrophag
fivposit
cat
suscept
intracellular
pathogen
includ
toxoplasma
gondii
listeria
monocytogen
even
earli
stage
retroviru
infect
clinic
sign
yet
observ
due
increas
level
decreas
level
describ
fivinfect
cat
present
studi
balanc
antiinflammatori
proinflammatori
cytokin
seem
key
factor
adequ
inflamm
fungal
infect
sinc
might
requir
limit
high
level
inflamm
consequ
host
damag
experiment
murin
sporotrichosi
involv
impair
fungicid
activ
macrophag
well
unrespons
tcell
human
high
level
product
respons
viral
infect
play
role
viral
persist
suppress
immun
function
high
level
fivposit
cat
studi
may
relat
high
percentag
regulatori
treg
cell
sinc
cell
directli
activ
fiv
normal
increas
infect
anim
regulatori
cell
measur
studi
ferreira
et
al
recent
shown
immun
requir
optim
fungal
clearanc
murin
model
system
sporotrichosi
although
role
arm
still
unknown
felin
sporotrichosi
level
cytokin
induc
develop
cell
differ
among
cat
studi
suggest
retroviru
coinfect
upregul
potenti
polar
treg
cell
profil
impair
immun
relev
despit
opposit
function
treg
cell
develop
cell
precursor
pathway
depend
upon
presenc
differ
cytokin
despit
low
level
detect
cat
studi
possibl
suggest
profil
depress
favor
treg
increas
retroviru
coinfect
due
small
number
fivposit
cat
anoth
limit
studi
absenc
control
group
healthi
cat
confirm
whether
level
alter
cat
sporotrichosi
coinfect
retroviru
infect
comparison
healthi
cat
although
first
step
fungushost
interact
consid
determin
adapt
respons
murin
model
scarciti
inform
innat
immun
felin
sporotrichosi
remain
concern
detriment
role
nitric
oxid
murin
immun
respons
schenckii
report
relat
tcell
suppress
fungal
dissemin
attribut
increas
apoptosi
signific
elev
interestingli
fiv
coinfect
cat
studi
present
higher
level
p
mwu
addit
shown
program
cell
death
protein
upregul
fivinfect
lymphocyt
may
correl
dysfunct
exhaust
cell
immunosuppress
infect
cat
could
specul
cytokin
chang
cat
sporotrichosi
coinfect
fiv
may
level
link
larg
number
yeast
commonli
found
cutan
lesion
felin
sporotrichosi
howev
work
requir
address
issu
properli
evalu
lymphocyt
subset
flow
cytometri
show
lower
percentag
cell
higher
percentag
cell
well
lower
ratio
fivposit
cat
compar
retrovirusneg
cat
find
consist
report
fiv
infect
invers
ratio
commonli
detect
along
decreas
level
increas
level
might
link
low
concentr
fivposit
cat
describ
studi
well
poor
gener
condit
cellular
immun
recent
refer
crucial
control
felin
sporotrichosi
presum
mechan
increas
percentag
cell
cat
good
gener
condit
local
lesion
wellorgan
granulomat
inflammatori
respons
low
fungal
burden
human
decreas
cell
count
also
correl
dissemin
sporotrichosi
poor
gener
condit
dissemin
lesion
high
fungal
burden
cat
sporotrichosi
relat
higher
low
cell
percentag
suggest
elicit
immun
background
coronaviru
infect
cat
develop
felin
infecti
periton
fip
fatal
granulomat
diseas
higher
tissu
level
probabl
prevent
excess
macrophag
activ
develop
fip
although
studi
still
necessari
determin
mechan
drive
ineffect
granuloma
felin
sporotrichosi
could
consid
describ
coronavirusinfect
cat
retroviru
coinfect
upregul
possibl
involv
impair
granuloma
format
increas
fungal
load
lesion
felin
sporotrichosi
cat
sever
sporotrichosi
clearli
outnumb
retroviru
coinfect
cat
thu
whether
cat
sever
sporotrichosi
neg
fiv
felv
truli
free
comorbid
immunosuppress
condit
remain
unknown
sinc
area
sporotrichosi
occur
rio
de
janeiro
low
educ
socioeconom
statu
poor
health
assist
infecti
diseas
sporotrichosi
spread
addit
vaccin
prophylact
deworm
statu
popul
cat
sporotrichosi
yet
determin
certainli
helminth
infect
typic
lead
increas
product
cytokin
downregul
cytokin
experiment
studi
rat
sporotrichosi
show
differ
profil
cytokin
driven
depend
coinfect
taenia
taeniaeformi
author
demonstr
increas
rat
coinfect
worm
anim
show
less
organ
inflammatori
infiltr
higher
fungal
burden
previous
specul
fiv
sporothrixhelminth
coinfect
could
lead
imbal
cytokin
result
impair
respons
sporothrix
lack
control
fungal
infect
cat
therefor
comorbid
consid
potenti
challeng
presenc
immunosuppress
condit
cours
sporotrichosi
cat
could
explain
occurr
relaps
worsen
clinic
condit
begin
treatment
therapeut
failur
studi
immunolog
chang
relat
retroviru
coinfect
cat
sporotrichosi
associ
differ
clinic
outcom
durat
treatment
still
combin
itz
ki
treatment
cat
decreas
median
treatment
length
cat
studi
even
though
reduct
statist
signific
import
state
combin
drug
previous
shown
promis
result
treatment
felin
sporotrichosi
effect
ki
prove
due
direct
action
fungi
mechan
use
success
remain
obscur
although
issu
still
need
address
potenti
immunomodul
suggest
could
contribut
shorter
treatment
length
cat
treat
ki
studi
especi
felv
coinfect
howev
studi
retrospect
design
retrospect
evalu
medic
record
prospect
doubl
blind
control
studi
perform
properli
assess
effect
differ
therapeut
regim
despit
effort
toward
better
understand
interact
sporothrix
spp
felin
immun
system
much
progress
perform
vitro
vivo
experiment
model
still
explor
cat
retrovirussporothrix
coinfect
cat
studi
led
import
chang
immunolog
balanc
lean
toward
immunosuppress
profil
higher
level
could
prevent
activ
respons
would
favour
sporotrichosi
consequ
imbal
hostpathogen
interact
may
potenti
result
higher
avail
sporothrix
skin
lesion
increas
transmiss
cat
human
inde
cat
sever
clinic
present
poor
gener
condit
coinfect
felv
fiv
therefor
result
encourag
develop
prospect
longitudin
studi
address
impact
immunolog
chang
outcom
cat
sporotrichosi
would
key
better
understand
prognost
determin
felin
sporotrichosi
develop
new
therapi
strategi
control
diseas
spread
